XML Financial LLC Sells 196 Shares of Stryker Corporation (NYSE:SYK)

XML Financial LLC cut its stake in Stryker Corporation (NYSE:SYK) by 5.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,364 shares of the medical technology company’s stock after selling 196 shares during the period. XML Financial LLC’s holdings in Stryker were worth $1,252,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of SYK. Brighton Jones LLC raised its stake in shares of Stryker by 15.4% in the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after acquiring an additional 609 shares during the last quarter. Private Advisor Group LLC raised its stake in shares of Stryker by 0.4% in the fourth quarter. Private Advisor Group LLC now owns 16,027 shares of the medical technology company’s stock worth $5,771,000 after acquiring an additional 60 shares during the last quarter. Callan Capital LLC raised its stake in shares of Stryker by 6.1% during the fourth quarter. Callan Capital LLC now owns 701 shares of the medical technology company’s stock worth $252,000 after buying an additional 40 shares during the last quarter. Pinnacle Financial Partners Inc raised its stake in shares of Stryker by 1.3% during the fourth quarter. Pinnacle Financial Partners Inc now owns 6,795 shares of the medical technology company’s stock worth $2,447,000 after buying an additional 84 shares during the last quarter. Finally, First Horizon Advisors Inc. raised its stake in shares of Stryker by 2.9% during the fourth quarter. First Horizon Advisors Inc. now owns 2,146 shares of the medical technology company’s stock worth $773,000 after buying an additional 61 shares during the last quarter. 77.09% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the transaction, the director now owns 3,417,326 shares of the company’s stock, valued at $1,288,195,208.96. This trade represents a 5.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 5.20% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on SYK shares. The Goldman Sachs Group set a $422.00 price target on shares of Stryker in a research note on Tuesday, March 4th. Needham & Company LLC reiterated a “buy” rating and issued a $442.00 target price on shares of Stryker in a report on Friday, March 21st. Sanford C. Bernstein set a $450.00 target price on shares of Stryker in a report on Monday, May 5th. JMP Securities reiterated a “market perform” rating on shares of Stryker in a report on Monday, May 5th. Finally, Roth Mkm increased their target price on shares of Stryker from $405.00 to $456.00 and gave the stock a “buy” rating in a report on Friday, May 2nd. Four equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $427.30.

Stryker Stock Up 0.6%

Stryker stock opened at $375.44 on Monday. The company has a market cap of $143.30 billion, a P/E ratio of 50.73, a price-to-earnings-growth ratio of 2.83 and a beta of 0.91. Stryker Corporation has a 1-year low of $314.93 and a 1-year high of $406.19. The company has a fifty day simple moving average of $374.95 and a 200 day simple moving average of $375.15. The company has a current ratio of 1.64, a quick ratio of 1.00 and a debt-to-equity ratio of 0.69.

Stryker (NYSE:SYK) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, beating analysts’ consensus estimates of $2.73 by $0.11. The business had revenue of $5.87 billion during the quarter, compared to the consensus estimate of $5.68 billion. Stryker had a net margin of 12.31% and a return on equity of 23.74%. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter last year, the firm earned $2.50 earnings per share. Research analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date is Monday, June 30th. Stryker’s dividend payout ratio (DPR) is presently 45.41%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.